BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30056769)

  • 1. Oncostatin M and its role in fibrosis.
    Stawski L; Trojanowska M
    Connect Tissue Res; 2019 Jan; 60(1):40-49. PubMed ID: 30056769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M modulates fibroblast function via signal transducers and activators of transcription proteins-3.
    Nagahama KY; Togo S; Holz O; Magnussen H; Liu X; Seyama K; Takahashi K; Rennard SI
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):582-91. PubMed ID: 23668543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
    Kwofie K; Scott M; Rodrigues R; Guerette J; Radford K; Nair P; Richards CD
    Respir Res; 2015 Feb; 16(1):14. PubMed ID: 25849622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inflammatory mediator oncostatin M induces angiopoietin 2 expression in endothelial cells in vitro and in vivo.
    Rychli K; Kaun C; Hohensinner PJ; Rega G; Pfaffenberger S; Vyskocil E; Breuss JM; Furnkranz A; Uhrin P; Zaujec J; Niessner A; Maurer G; Huber K; Wojta J
    J Thromb Haemost; 2010 Mar; 8(3):596-604. PubMed ID: 20088942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms.
    Blanchard F; Wang Y; Kinzie E; Duplomb L; Godard A; Baumann H
    J Biol Chem; 2001 Dec; 276(50):47038-45. PubMed ID: 11602599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential roles of oncostatin M receptor β signaling in renal crystal formation in mice.
    Yamashita S; Komori T; Kohjimoto Y; Miyajima A; Hara I; Morikawa Y
    Sci Rep; 2020 Oct; 10(1):17150. PubMed ID: 33051515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ.
    Demyanets S; Kaun C; Rychli K; Pfaffenberger S; Kastl SP; Hohensinner PJ; Rega G; Katsaros KM; Afonyushkin T; Bochkov VN; Paireder M; Huk I; Maurer G; Huber K; Wojta J
    Basic Res Cardiol; 2011 Mar; 106(2):217-31. PubMed ID: 21174212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
    Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
    Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide.
    Repovic P; Mi K; Benveniste EN
    Glia; 2003 Jun; 42(4):433-46. PubMed ID: 12730964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the oncostatin M/OSM receptor β axis in activating dermal microvascular endothelial cells in systemic sclerosis.
    Marden G; Wan Q; Wilks J; Nevin K; Feeney M; Wisniacki N; Trojanowski M; Bujor A; Stawski L; Trojanowska M
    Arthritis Res Ther; 2020 Jul; 22(1):179. PubMed ID: 32736577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
    Underhill-Day N; Heath JK
    Cancer Res; 2006 Nov; 66(22):10891-901. PubMed ID: 17108126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
    Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
    Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation.
    Boniface K; Diveu C; Morel F; Pedretti N; Froger J; Ravon E; Garcia M; Venereau E; Preisser L; Guignouard E; Guillet G; Dagregorio G; Pène J; Moles JP; Yssel H; Chevalier S; Bernard FX; Gascan H; Lecron JC
    J Immunol; 2007 Apr; 178(7):4615-22. PubMed ID: 17372020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis.
    Han L; Yan J; Li T; Lin W; Huang Y; Shen P; Ba X; Huang Y; Qin K; Geng Y; Wang H; Zheng K; Liu Y; Wang Y; Chen Z; Tu S
    Front Immunol; 2023; 14():1258765. PubMed ID: 38022540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical relevance of OSM in inflammatory diseases: a comprehensive review.
    Wolf CL; Pruett C; Lighter D; Jorcyk CL
    Front Immunol; 2023; 14():1239732. PubMed ID: 37841259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncostatin M-dependent Mcl-1 induction mediated by JAK1/2-STAT1/3 and CREB contributes to bioenergetic improvements and protective effects against mitochondrial dysfunction in cortical neurons.
    Chang SH; Hwang CS; Yin JH; Chen SD; Yang DI
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2306-25. PubMed ID: 25986861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
    Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
    Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection.
    Larrea E; Echeverria I; Riezu-Boj JI; Aldabe R; Guembe L; Sola I; Civeira MP; Sarobe P; Prieto J
    J Hepatol; 2014 Mar; 60(3):482-9. PubMed ID: 24418171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of OSM and IL-6 impacts the polarization of pro-fibrotic macrophages and the development of bleomycin-induced lung fibrosis.
    Ayaub EA; Dubey A; Imani J; Botelho F; Kolb MRJ; Richards CD; Ask K
    Sci Rep; 2017 Oct; 7(1):13281. PubMed ID: 29038604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor 1alpha is up-regulated by oncostatin M and participates in oncostatin M signaling.
    Vollmer S; Kappler V; Kaczor J; Flügel D; Rolvering C; Kato N; Kietzmann T; Behrmann I; Haan C
    Hepatology; 2009 Jul; 50(1):253-60. PubMed ID: 19441100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.